Compass Therapeutics (CMPX) Cash from Operations (2018 - 2026)
Compass Therapeutics recorded quarterly Cash from Operations of 17269000.0 in Q1 2026, down 30.29% quarter-over-quarter from 13254000.0 in Q4 2025, and down 30.75% year-over-year from 24935930.03 in Q1 2025.
Compass Therapeutics' Cash from Operations history runs 9 years deep, the most recent figure standing at 17269000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 30.75% year-over-year to 17269000.0; the TTM figure through Mar 2026 stood at 53204000.0 (down 20.44% YoY), while the FY2025 annual figure was 49143000.0, down 9.56% from the prior year.
- Cash from Operations came in at 17269000.0 for Q1 2026 at Compass Therapeutics, down from 13254000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 4600000.0 in Q2 2022 to a low of 17269000.0 in Q1 2026.
- A 5-year average of 10941764.71 and a median of 10942000.0 in 2022 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations sank 216.52% in 2022 and jumped 45.88% in 2023, its largest moves.
- Compass Therapeutics' Cash from Operations stood at 10641000.0 in 2022, then dropped by 16.1% to 12354000.0 in 2023, then rose by 25.84% to 9162000.0 in 2024, then sank by 44.66% to 13254000.0 in 2025, then slumped by 30.29% to 17269000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 17269000.0, 13254000.0, and 10849000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Compass Therapeutics | 418.47 Mn | 223.78 Mn | - | -17.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.27 Mn |
| Mar 31, 2026 | -17.27 Mn |
| Dec 31, 2025 | -13.25 Mn |
| Dec 31, 2025 | -13.25 Mn |
| Sep 30, 2025 | -10.85 Mn |
| Sep 30, 2025 | -10.85 Mn |
| Jun 30, 2025 | -11.83 Mn |
| Jun 30, 2025 | -11.83 Mn |
| Mar 31, 2025 | -13.21 Mn |
| Mar 31, 2025 | -13.21 Mn |
| Dec 31, 2024 | -9.16 Mn |
| Dec 31, 2024 | -9.16 Mn |
| Sep 30, 2024 | -11.05 Mn |
| Sep 30, 2024 | -11.05 Mn |
| Jun 30, 2024 | -10.75 Mn |
| Jun 30, 2024 | -10.75 Mn |
| Mar 31, 2024 | -13.89 Mn |
| Mar 31, 2024 | -13.89 Mn |
| Dec 31, 2023 | -12.35 Mn |
| Dec 31, 2023 | -12.35 Mn |
| Sep 30, 2023 | -5.92 Mn |
| Sep 30, 2023 | -5.92 Mn |
| Jun 30, 2023 | -10.11 Mn |
| Jun 30, 2023 | -10.11 Mn |
| Mar 31, 2023 | -12.23 Mn |
| Mar 31, 2023 | -12.23 Mn |
| Dec 31, 2022 | -10.64 Mn |
| Dec 31, 2022 | -10.64 Mn |
| Sep 30, 2022 | -10.94 Mn |
| Sep 30, 2022 | -10.94 Mn |
| Jun 30, 2022 | -4.60 Mn |
| Jun 30, 2022 | -4.60 Mn |
| Mar 31, 2022 | -7.94 Mn |
| Mar 31, 2022 | -7.94 Mn |
| Dec 31, 2021 | -4.67 Mn |
| Dec 31, 2021 | -4.67 Mn |
| Sep 30, 2021 | -3.46 Mn |
| Sep 30, 2021 | -3.46 Mn |
| Jun 20, 2021 | -5.94 Mn |
| Jun 20, 2021 | -5.94 Mn |
| Mar 31, 2021 | -5.61 Mn |
| Mar 31, 2021 | -5.61 Mn |
| Sep 30, 2020 | -20.23 Mn |
| Sep 30, 2020 | -20.23 Mn |
| Jun 30, 2020 | -13.06 Mn |
| Jun 30, 2020 | -13.06 Mn |
| Mar 31, 2020 | -7.76 Mn |
| Mar 31, 2020 | -7.76 Mn |
| Dec 31, 2019 | -24,707.00 |
| Dec 31, 2019 | -24,707.00 |
| Sep 30, 2019 | -26.15 Mn |
| Sep 30, 2019 | -26.15 Mn |
| Jun 30, 2019 | -19.45 Mn |
| Jun 30, 2019 | -19.45 Mn |
| Dec 31, 2018 | -10,267.00 |
| Dec 31, 2018 | -10,267.00 |
| Jun 30, 2018 | -7,894.00 |
| Jun 30, 2018 | -7,894.00 |